Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Folci

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Journal of Autoimmunity|July 28, 2020
Interleukin-6 receptor blocking with intravenous tocilizumab in COVID-19 severe acute respiratory distress syndrome: A retrospective case-control survival analysis of 128 patientsLorenzo M Canziani, Serena Trovati, Enrico Brunetta, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 10, 2018
Transcutaneously refillable nanofluidic implant achieves sustained level of tenofovir diphosphate for HIV pre-exposure prophylaxisCorrine Ying Xuan Chua, Priya Jain, Andrea Ballerini, et al.
Annals of the Rheumatic Diseases|July 19, 2022
Sequential rituximab and mepolizumab in eosinophilic granulomatosis with polyangiitis (EGPA): a European multicentre observational studyAlessandra Bettiol, Maria Letizia Urban, Federica Bello, et al.
Frontiers in Immunology|April 16, 2014
Genome-wide analysis of DNA methylation, copy number variation, and gene expression in monozygotic twins discordant for primary biliary cirrhosisCarlo Selmi, Francesca Cavaciocchi, Ana Lleo, et al.
Nature Immunology|November 19, 2020
Macrophage expression and prognostic significance of the long pentraxin PTX3 in COVID-19Enrico Brunetta, Marco Folci, Barbara Bottazzi, et al.
Annals of the Rheumatic Diseases|September 21, 2023
Dupilumab for relapsing or refractory sinonasal and/or asthma manifestations in eosinophilic granulomatosis with polyangiitis: a European retrospective studyBerengere Molina, Roberto Padoan, Maria Letizia Urban, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 4, 2021
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational StudyAlessandra Bettiol, Maria Letizia Urban, Lorenzo Dagna, et al.
The Lancet. Rheumatology|January 22, 2024
Benralizumab for eosinophilic granulomatosis with polyangiitis: a retrospective, multicentre, cohort studyAlessandra Bettiol, Maria Letizia Urban, Roberto Padoan, et al.
Journal of Autoimmunity|March 27, 2025
Mepolizumab versus benralizumab for eosinophilic granulomatosis with polyangiitis (EGPA): A European real-life retrospective comparative studyIrene Mattioli, Maria Letizia Urban, Roberto Padoan, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Journal of Autoimmunity|July 28, 2020
Interleukin-6 receptor blocking with intravenous tocilizumab in COVID-19 severe acute respiratory distress syndrome: A retrospective case-control survival analysis of 128 patientsLorenzo M Canziani, Serena Trovati, Enrico Brunetta, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 10, 2018
Transcutaneously refillable nanofluidic implant achieves sustained level of tenofovir diphosphate for HIV pre-exposure prophylaxisCorrine Ying Xuan Chua, Priya Jain, Andrea Ballerini, et al.
Annals of the Rheumatic Diseases|July 19, 2022
Sequential rituximab and mepolizumab in eosinophilic granulomatosis with polyangiitis (EGPA): a European multicentre observational studyAlessandra Bettiol, Maria Letizia Urban, Federica Bello, et al.
Frontiers in Immunology|April 16, 2014
Genome-wide analysis of DNA methylation, copy number variation, and gene expression in monozygotic twins discordant for primary biliary cirrhosisCarlo Selmi, Francesca Cavaciocchi, Ana Lleo, et al.
Nature Immunology|November 19, 2020
Macrophage expression and prognostic significance of the long pentraxin PTX3 in COVID-19Enrico Brunetta, Marco Folci, Barbara Bottazzi, et al.
Annals of the Rheumatic Diseases|September 21, 2023
Dupilumab for relapsing or refractory sinonasal and/or asthma manifestations in eosinophilic granulomatosis with polyangiitis: a European retrospective studyBerengere Molina, Roberto Padoan, Maria Letizia Urban, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 4, 2021
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational StudyAlessandra Bettiol, Maria Letizia Urban, Lorenzo Dagna, et al.
The Lancet. Rheumatology|January 22, 2024
Benralizumab for eosinophilic granulomatosis with polyangiitis: a retrospective, multicentre, cohort studyAlessandra Bettiol, Maria Letizia Urban, Roberto Padoan, et al.
Journal of Autoimmunity|March 27, 2025
Mepolizumab versus benralizumab for eosinophilic granulomatosis with polyangiitis (EGPA): A European real-life retrospective comparative studyIrene Mattioli, Maria Letizia Urban, Roberto Padoan, et al.
Pageof 3